New HPV Vaccine on Horizon: Will it Also Contain DNA Fragments?

April 16, 2012 - PRLog -- The Center for the Biology of Chronic Disease (CBCD) has recently learned that that preclinical data generated by researchers at The Johns Hopkins University School of Medicine, USA regarding AAVLP vaccine technology developed by the biotech company, MediGene AG, will be presented today at the World Vaccine Congress 2012 in Washington DC, US.

The biotech’s information shows that mice vaccinated with an AAVLP vaccine carrying HPV L2 epitopes at two surface sites induces cross-neutralizing antibodies active against several HPV types, and supplies stable protection against vaginal HPV challenge over three months when using a clinically relevant mixture that elicits a strong immune response.

The CBCD is watching the development of this new vaccine against HPV with great interest. Why? Because, the AAVLP vaccine technology is based on Adeno-associated virus-like particles which hold potential as prophylactic and therapeutic vaccines against cancer and infections according to MediGene AG.

If these virus-like particles are anything like the virus-like particles used in the development of the FDA approved HPV vaccine, Gardasil then this new vaccine will also contain DNA fragments. The FDA has acknowledged that Gardasil contains viral DNA fragments. [1]

According to the theory of Microcompetition, this could pose a problem.

While the FDA says on their website: “The presence of DNA fragments is expected in Gardasil and not evidence of contamination.” and “Gardasil does contain recombinant HPV L1-specific DNA fragments, but these are not contaminants. DNA encoding the HPV L1 gene is used in the vaccine manufacturing process to produce the virus-like particles that make up the vaccine. The presence of these DNA fragments is expected, is not a risk to vaccine recipients, and is not a safety factor.”

The CBCD however, believes that knowledge is power. The issue is not one of contamination, but rather the fact that the inclusion of DNA fragments is simply a by-product of the vaccine manufacturing process. No known process can remove DNA 100% from the vaccine, and now a new vaccine is being developed against HPV that will also likely contain DNA fragments.

In an effort to bring to light a ground breaking new theory we believe will challenge and change the underlying foundations currently held in microbiology, the CBCD is encouraging biologists, virologists, geneticists and scientists in general to obtain a copy of “Microcompetition with Foreign DNA and the Origin of Chronic Disease.” This book was written by Dr. Hanan Polansky.

The CBCD believes Dr. Polansky’s findings may indeed be a huge blow to the paradigm held by the pharmaceutical industry as a whole and to the FDA in particular if Dr. Polansky’s theory proves to be true.

The book is available as a free download from the CBCD website. (http://www.cbcd.net )

The theory identifies the origin of many chronic diseases, such as Multiple Sclerosis, hepatitis, atherosclerosis, stroke, cancer, obesity, diabetes, lupus, thyroiditis, osteoarthritis, rheumatoid arthritis, and alopecia.

“I found that the theory is groundbreaking and will likely open doors to many exciting research areas and treatment options … biology and medicine lag behind and remain experimental disciplines, which are heavy on experimental data but thin on applicable theories that could guide future directions. In this sense, Dr. Polansky’s book is nothing short of revolutionary.” - Liqun Zhang, PhD - Research Associate, Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill

The CBCD endorses Dr. Polansky’s theory and invites both the media as well as scholars to contact us for dialogue regarding the theory.

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with Dr. Polansky on the subject of Microcompetition with Foreign DNA, please visit http://www.cbcd.net or call 585-250-9999.

References:

[1]http://www.fda.gov/BiologicsBloodVaccines/Vaccines/Approv...

# # #

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” written by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

We invite biologists, virologists, and scientists everywhere to download Dr. Polansky’s book here: http://cbcd.net/.